Atlas Trials

Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis

Clinical trial NCT02555800 · UNKNOWN

Trial details

NCT number
NCT02555800
Sponsor
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Respiratory Papillomatosis
Start date
2014-12-01
Primary completion
2016-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.